SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-100077
Filing Date
2023-12-29
Accepted
2023-12-29 17:20:23
Documents
1
Period of Report
2023-12-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4172
  Complete submission text file 0001213900-23-100077.txt   5652
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Issuer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 955 HARTMAN RUN ROAD MORGANTOWN WV 26507
Business Address
O'Loughlin Steve (Reporting) CIK: 0001615840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36374 | Film No.: 231528646